USFDA Closes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification
Dr Reddys Laboratories Ltd 路 Others (Uncategorized) 路 28 Oct 2026, 11:59 pm
USFDA Closes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification Dr. Reddy鈥檚 Laboratories announced that the USFDA has classified the inspection outcome for its FTO-SEZ Process Unit-02 located in Srikakulam, Andhra Pradesh, as Voluntary Action Indicated (VAI). The Pre-Approval Inspection (PAI) and Good Manufacturing Practices (GMP) audit, originally intimated on 29th Jul'26, is now officially closed under 21 CFR 20.64(d)(3). The VAI status removes regulatory overhang for the facility, clearing a key compliance hurdle for pending and future US product approvals from the site.
Original exchange filing (PDF)
More announcements from Dr Reddys Laboratories Ltd
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 14 Nov 2026
- Intimation of Analyst meet 路 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 05 Nov 2026
- Allotment of Employee Stock options 路 04 Nov 2026
- Clarification - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) .... 路 03 Nov 2026
- Transcript of Earnings call 路 30 Oct 2026
- Audio Recording of the Earnings call conducted on October 23, 2026 路 24 Oct 2026
